PLGA and PLLA nanoparticles encapsulating microparticles provide sequential release of three NSAID drugs
Drug delivery systems (DDSs) are versatile vessels, capable of carrying dyes, proteins, drugs and chemicals and delivering them at targeted sites, improving patient compliance, drug stability and potency, while reducing physiological fatigue from frequent high doses, infection, as well as the del...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Final Year Project |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/66787 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | Drug delivery systems (DDSs) are versatile vessels, capable of carrying dyes, proteins, drugs and
chemicals and delivering them at targeted sites, improving patient compliance, drug stability and
potency, while reducing physiological fatigue from frequent high doses, infection, as well as the
delivery of one or more potentially incompatible drug in a single dose.
Micro and nanoparticles prepared using aliphatic polyesters such as poly (L-lactide), poly (Llactide-
co-glycolide), and polycaprolactone present the gift of manufacturing DDSs which are
smaller, less invasive to the patient, and more target specific, while keeping intended doses at
therapeutic levels. There have been limited studies with respect to the use of particulate DDSs, let
alone encapsulation of nanoparticles within a microcapsule.
A study was carried out to develop and fabricate a DDS comprising of dye- and drug-loaded
nanoparticles in microcapsules using aliphatic polyesters. This was done using a double emulsion
solvent evaporation method, before proceeding to explore the release of three model non-steroidal
anti-inflammatory drugs in a controlled, sustained fashion by polymeric hydrolytic degradation,
and diffusion of drugs from the DDS within a simulated in-vitro environment of phosphate buffer
solution at the physiological pH of 7.4.
The proposed DDS was found to successfully encapsulate nanoparticles within microcapsules
through qualitative imaging methods of confocal laser scanning microscopy and scanning electron
microscopy, and portrayed sequential release profiles as particulate DDSs consisting of
microcapsule encapsulation. This study has unlocked a vast potential of exploring many possible
formulations of drugs over 15 days in simulated in-vitro physiological conditions at pH7.4. |
---|